Table 6.
Postoperative Outcomes and Serum anti-TNFα Drug Levels in UC Cohort
| UC Cohort (n=94) | Undetectable Level (n=77) | Detectable Level (n=17) | P | |
|---|---|---|---|---|
| Postoperative morbidity | 39 (41) | 31 (40) | 8 (47) | 0.61 | 
| Medical complications | 11 (12) | 8 (10) | 3 (18) | 0.41 | 
| Major | 4 (4) | 3 (4) | 1 (6) | 0.72 | 
| Minor | 7 (7) | 5 (6) | 2 (12) | 0.46 | 
| Surgical complications | 29 (31) | 24 (31) | 5 (29) | 1.00 | 
| Major | 10 (11) | 8 (10) | 2 (12) | 0.87 | 
| Minor | 19 (20) | 16 (21) | 3 (18) | 0.77 | 
| Infectious complications | 12 (13) | 10 (13) | 2 (12) | 0.89 | 
| Mean postoperative LOS (d) | 6.3 (2.1) | 6.3 (2.1) | 6.0 (2.3) | 0.54 | 
| Readmission within 30 days | 19 (20) | 15 (19) | 4 (23) | 0.71 | 
All values in parentheses denote % except postoperative length of stay (standard deviation)
LOS length of stay